Needle Free Injection System Market worth 20.17 Billion USD by 2021

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. 

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=165815861

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market in 2016, Europe is expected to grow at the highest CAGR during the forecast period.  The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe

Global Needle Free Injection System Market, By Product 

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Global Needle Free Injection System Market, By Technology

• Jet-Based Needle-Free Injectors
• Spring-Based Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

Global Needle Free Injection System Market, By Usability

• Reusable Needle-Free Injectors
• Disposable Needle-Free Injectors

Global Needle Free Injection System Market, by type of Medication

• Liquid-based needle free injectors
• Powder-based needle free injectors
• Projectile/depot-based needle free injectors

Global Needle Free Injection System Market, by Site of Delivery

• Intra dermal injectors
• Intramuscular injectors
• Subcutaneous injectors

Global Needle Free Injection System Market, by Application

• Vaccine Needle free delivery
• Insulin Needle free delivery
• Pain Management Needle free delivery
• Oncology Needle free delivery
• Others applications

Global Needle Free Injection System Market, by End User

• Hospitals and Clinics
• Homecare Settings
• Research Laboratories
• Pharmaceutical and Biotechnology companies
• Other End Users 

Key players in the needle-free injection system market include  Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).